ENTBF (Entheon Biomedical) Gross Margin %: 0.00% (As of Feb. 2026)

Entheon Biomedical  (OTCPK:ENTBF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Entheon Biomedical had a gross margin of N/A% for the quarter that ended in Feb. 2026 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Entheon Biomedical Gross Margin % Related Terms

The historical data trend for Entheon Biomedical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Gross Margin % Chart

Entheon Biomedical Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Nov21	Nov22	Nov23	Nov24	Nov25
Gross Margin %		Get a 7-Day Free Trial				0.00	0.00	0.00	0.00	0.00

Entheon Biomedical Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
Gross Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ENTBF vs VRTX, REGN, ALNY: Gross Margin % Comparison

For the Biotechnology subindustry, Entheon Biomedical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Gross Margin % falls into.

Entheon Biomedical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Entheon Biomedical's Gross Margin for the fiscal year that ended in Nov. 2025 is calculated as

Entheon Biomedical's Gross Margin for the quarter that ended in Feb. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Entheon Biomedical Business Description